tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BIIB Stock Latest News

Morning Movers: Alphabet, Eli Lilly rise following quarterly results
The FlyMorning Movers: Alphabet, Eli Lilly rise following quarterly results
11h ago
CI
MA
Biogen’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
PremiumRatings
Biogen’s Strong Financial Performance and Strategic Positioning Justify Buy Rating
11h ago
BIIB
Biogen reports Q3 EPS $4.81, consensus $3.88
PremiumThe Fly
Biogen reports Q3 EPS $4.81, consensus $3.88
14h ago
BIIB
Biogen lowers FY25 EPS view to $14.50-$15.00 from $15.50-$16.00
PremiumThe Fly
Biogen lowers FY25 EPS view to $14.50-$15.00 from $15.50-$16.00
14h ago
BIIB
Notable companies reporting before tomorrow’s open
PremiumThe Fly
Notable companies reporting before tomorrow’s open
1d ago
K
CI
BIIB Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsBIIB Upcoming Earnings Report: What to Expect?
3d ago
BIIB
Biogen’s Strategic Positioning and Promising Pipeline Drive Buy Rating
Premium
Ratings
Biogen’s Strategic Positioning and Promising Pipeline Drive Buy Rating
3d ago
BIIB
Biogen’s PMN Study: A Potential Game-Changer for Kidney Disease Treatment?
Premium
Company Announcements
Biogen’s PMN Study: A Potential Game-Changer for Kidney Disease Treatment?
3d ago
BIIB
Biogen’s Felzartamab Trial: A New Hope for Kidney Transplant Patients
PremiumCompany Announcements
Biogen’s Felzartamab Trial: A New Hope for Kidney Transplant Patients
3d ago
BIIB
Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment?
PremiumCompany Announcements
Biogen’s Litifilimab Study: A Potential Game-Changer for Lupus Treatment?
3d ago
BIIB
Biogen’s Litifilimab Study: A Promising Step for Lupus Treatment
PremiumCompany Announcements
Biogen’s Litifilimab Study: A Promising Step for Lupus Treatment
3d ago
BIIB
Biogen’s New Study on Felzartamab: A Potential Game-Changer for Kidney Transplant Patients
PremiumCompany Announcements
Biogen’s New Study on Felzartamab: A Potential Game-Changer for Kidney Transplant Patients
3d ago
BIIB
Biogen’s Study on Diroximel Fumarate: A Closer Look at Pregnancy Outcomes
PremiumCompany AnnouncementsBiogen’s Study on Diroximel Fumarate: A Closer Look at Pregnancy Outcomes
3d ago
BIIB
Biogen’s Promising Study on Litifilimab for Lupus: A Potential Game-Changer
Premium
Company Announcements
Biogen’s Promising Study on Litifilimab for Lupus: A Potential Game-Changer
3d ago
BIIB
Biogen’s Felzartamab Study: A Potential Game-Changer for IgA Nephropathy
Premium
Company Announcements
Biogen’s Felzartamab Study: A Potential Game-Changer for IgA Nephropathy
3d ago
BIIB
Biogen’s Litifilimab Study: A Potential Game-Changer in Lupus Treatment?
PremiumCompany Announcements
Biogen’s Litifilimab Study: A Potential Game-Changer in Lupus Treatment?
3d ago
BIIB
Biogen’s New Study on Omaveloxolone: A Potential Game-Changer for Young Patients with Friedreich’s Ataxia
PremiumCompany Announcements
Biogen’s New Study on Omaveloxolone: A Potential Game-Changer for Young Patients with Friedreich’s Ataxia
3d ago
BIIB
Biogen’s Nusinersen Study: Exploring Pregnancy Outcomes in SMA Patients
PremiumCompany Announcements
Biogen’s Nusinersen Study: Exploring Pregnancy Outcomes in SMA Patients
3d ago
BIIB
Biogen’s Innovative Approach in SMA Treatment: ThecaFlex DRx™ System Study Update
PremiumCompany Announcements
Biogen’s Innovative Approach in SMA Treatment: ThecaFlex DRx™ System Study Update
3d ago
BIIB
Biogen’s New Study on Omaveloxolone: A Potential Game-Changer for Friedreich’s Ataxia
PremiumCompany AnnouncementsBiogen’s New Study on Omaveloxolone: A Potential Game-Changer for Friedreich’s Ataxia
3d ago
BIIB
Biogen’s BIIB142 Study: A New Chapter in Drug Safety Evaluation
Premium
Company Announcements
Biogen’s BIIB142 Study: A New Chapter in Drug Safety Evaluation
3d ago
BIIB
Biogen’s Innovative Approach to SMA Treatment: A Study Update
Premium
Company Announcements
Biogen’s Innovative Approach to SMA Treatment: A Study Update
3d ago
BIIB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >